Platelet-derived microvesicles (PMVs) in cancer progression and clinical applications
Clin. transl. oncol. (Print)
; 25(4): 873-881, abr. 2023.
Artigo
em Inglês
| IBECS
| ID: ibc-217748
Biblioteca responsável:
ES1.1
Localização: ES15.1 - BNCS
ABSTRACT
Platelet-derived microvesicles (PMVs), the microvesicles with the highest concentration in the bloodstream, play a key role in the regulation of hemostasis, inflammation, and angiogenesis. PMVs have recently been identified as key factors in the link between platelets and cancer. PMVs bind to both cancer cells and nontransformed cells in the microenvironment of the tumor, and then transfer platelet-derived contents to the target cell. These contents have the potential to either stimulate or modulate the target cell's response. PMVs are encased in a lipid bilayer that contains surface proteins and lipids as well as components found inside the PMV. Each of these components participates in known and potential PMV roles in cancer. The complicated roles played by PMVs in the onset, development, and progression of cancer and cancer-related comorbidities are summarized in this study (AU)
Buscar no Google
Coleções:
Bases de dados nacionais
/
Espanha
Base de dados:
IBECS
Assunto principal:
Micropartículas Derivadas de Células
/
Neoplasias
Limite:
Humanos
Idioma:
Inglês
Revista:
Clin. transl. oncol. (Print)
Ano de publicação:
2023
Tipo de documento:
Artigo
Instituição/País de afiliação:
Quzhou Peoples Hospital/China
/
Zhejiang University School of Medicine/China